These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12441330)

  • 1. Re: Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.
    Ferretti G; Di Cosimo S; Carlini P; Papaldo P; Fabi A; Cognetti F
    J Natl Cancer Inst; 2002 Nov; 94(22):1720; author reply 1721-2. PubMed ID: 12441330
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.
    Milella M; Giannarelli D; Ferraresi V; Mottolese M; Botti C; Nisticò C
    J Natl Cancer Inst; 2002 Nov; 94(22):1719-20; author reply 1721-2. PubMed ID: 12441328
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.
    Hrushesky WJ
    J Natl Cancer Inst; 2002 Nov; 94(22):1720-1. PubMed ID: 12441329
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: The influence of menstrual cycle phase on surgical treatment of primary breast cancer: have we made any progress over the past 13 years?
    Love RR; Allred DC; DeMets DL
    J Natl Cancer Inst; 2002 Nov; 94(22):1722-3; author reply 1723. PubMed ID: 12441332
    [No Abstract]   [Full Text] [Related]  

  • 5. Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.
    Love RR; Duc NB; Dinh NV; Shen TZ; Havighurst TC; Allred DC; DeMets DL
    J Natl Cancer Inst; 2002 May; 94(9):662-9. PubMed ID: 11983754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of adjuvant surgical oophorectomy in the menstrual cycle and disease-free and overall survival in premenopausal women with operable breast cancer.
    Love RR; Laudico AV; Van Dinh N; Allred DC; Uy GB; Quang le H; Salvador JD; Siguan SS; Mirasol-Lumague MR; Tung ND; Benjaafar N; Navarro NS; Quy TT; De La Peña AS; Dofitas RB; Bisquera OC; Linh ND; To TV; Young GS; Hade EM; Jarjoura D
    J Natl Cancer Inst; 2015 Jun; 107(6):djv064. PubMed ID: 25794890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on survival of menstrual cycle phase of adjuvant surgical oophorectomy in premenopausal women with breast cancer.
    Love RR; Young GS; Hade EM; Jarjoura D
    Breast Cancer Res Treat; 2011 Apr; 126(2):479-85. PubMed ID: 21293921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progesterone receptor content in breast epithelial cells from healthy women during the menstrual cycle.
    Söderqvist G; von Schoultz B; Tani E; Skoog L
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):874-9. PubMed ID: 8456895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Status of estrogen and progesterone receptors in various phases of the menstrual cycle in breast cancer.
    Vasei M; Azarpira N; Talei A
    Arch Iran Med; 2006 Jul; 9(3):250-3. PubMed ID: 16859061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in estrogen and progesterone receptor content of primary breast carcinoma during the menstrual cycle.
    Weimer DA; Donegan WL
    Breast Cancer Res Treat; 1987 Dec; 10(3):273-8. PubMed ID: 3447646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of receptor phenotypes in operated breast cancer.
    Cherubini M; Dell' Antonio A; Sustersich M
    J Chemother; 1997 Apr; 9(2):117-8. PubMed ID: 9176751
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant Surgical Oophorectomy Plus Tamoxifen in Premenopausal Women With Operable Hormone Receptor-Positive Breast Cancer: A Global Treatment Option.
    Love RR
    Clin Breast Cancer; 2016 Aug; 16(4):233-7. PubMed ID: 27117241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer.
    Love RR; Duc NB; Allred DC; Binh NC; Dinh NV; Kha NN; Thuan TV; Mohsin SK; Roanh le D; Khang HX; Tran TL; Quy TT; Thuy NV; Thé PN; Cau TT; Tung ND; Huong DT; Quang le M; Hien NN; Thuong L; Shen TZ; Xin Y; Zhang Q; Havighurst TC; Yang YF; Hillner BE; DeMets DL
    J Clin Oncol; 2002 May; 20(10):2559-66. PubMed ID: 12011136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03).
    Takei H; Suemasu K; Inoue K; Saito T; Okubo K; Koh J; Sato K; Tsuda H; Kurosumi M; Tabei T;
    Breast Cancer Res Treat; 2008 Jan; 107(1):87-94. PubMed ID: 18043897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
    Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteal versus follicular phase surgical oophorectomy plus tamoxifen in premenopausal women with metastatic hormone receptor-positive breast cancer.
    Love RR; Hossain SM; Hussain MM; Mostafa MG; Laudico AV; Siguan SS; Adebamowo C; Sun JZ; Fei F; Shao ZM; Liu Y; Akram Hussain SM; Zhang B; Cheng L; Panigaro S; Walta F; Chuan JH; Mirasol-Lumague MR; Yip CH; Navarro NS; Huang CS; Lu YS; Ferdousy T; Salim R; Akhter C; Nahar S; Uy G; Young GS; Hade EM; Jarjoura D
    Eur J Cancer; 2016 Jun; 60():107-16. PubMed ID: 27107325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.
    Pujol P; Daures JP; Brouillet JP; Chang S; Rouanet P; Bringer J; Grenier J; Maudelonde T
    Cancer; 2001 May; 91(10):1854-61. PubMed ID: 11346866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menstrual cycle and hormone receptor status in breast cancer patients.
    Atalay C; Kanliöz M; Altinok M
    Neoplasma; 2002; 49(4):278. PubMed ID: 12382029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer?
    Parker CC; Ampil F; Burton G; Li BD; Chu QD
    Surgery; 2010 Aug; 148(2):386-91. PubMed ID: 20580045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.